SECsense Logo

Aptose Biosciences Inc. 8-K Filing: Key Financial Updates for Investors

$APTO
Form 8-K
Filed on: 2025-02-20
Source
Aptose Biosciences Inc. 8-K Filing: Key Financial Updates for Investors

Based on the provided XML section from the financial report, here are the key extracted insights:

  1. Filing Type: The document is an 8-K filing, which is typically used to report major events that shareholders should know about.
  2. Company Information:
  • Name: Aptose Biosciences Inc.
  • CIK Code: 0000882361
  • IRS Employer Identification Number: 98-1136802
  • Address: 66 Wellington Street West, Suite 5300, TD Bank Tower, Box 48, Toronto, ON M5K 1E6
  • Phone Number: 310-849-8060
  • Stock Ticker: APTO
  • Exchange: NASDAQ
  1. Reporting Period:
  • Date of Report: February 20, 2025.
  • This date suggests it is a current report regarding events or changes occurring on the same day.
  1. Security Information:
  • Type of Security: Common Shares, no par value.
  • This indicates that the company has issued common stock without a par value, which is common in many jurisdictions.
  1. Measurement Units:
  • Currency is reported in USD (United States Dollar).
  • Shares are noted as a separate measurement unit.

Overall, this financial report segment provides essential information about the company and its recent reporting activities. It indicates the nature of the event being reported (likely significant to investors) and provides identifiers and contact information for further inquiries.